PVRIG and neoplasm: In addition, we systemically characterized the mechanism by which PVRIG blockade induces tumor killing via NK cell activation rather than T-cell activation and show that the effector function of competent Fc is necessary for the antitumor efficacy of PVRIG blockade in preclinical models.